ACIDYLATED HETEROARYLCONDENSED CYCLOALKENYLAMINES AND THEIR USE AS PHARMACEUTICAL AGENTS Russian patent published in 2008 - IPC C07D401/12 C07D403/12 C07D409/12 A61K31/435 

Abstract RU 2338743 C2

FIELD: chemistry.

SUBSTANCE: invention pertains to acidylated heteroarylcondensed cycloalkenylamines with formula I in any of their stereoisomeric form or in form of their mixtures in any ratio, or their pharmaceutical salts, where in formula I: ring A represents an aromatic 6-member ring, containing 1 nitrogen atom, or a 5-member aromatic ring, containing 1 sulphur atom; one or two of R1, R2, R3 and R4 is independently chosen from a group consisting of hydrogen, halogen or C1-C4-alkyl, and the other R1, R2, R3 and R4 represent hydrogen; R5 represents an Ar group or Hetar group. Description is also given of a pharmaceutical composition based on compound with formula I and use of the latter.

EFFECT: regulation of the expression of the enzyme endothelial NO-synthesis.

10 cl, 31 ex

Similar patents RU2338743C2

Title Year Author Number
ACIDIFIED ARYLCYCLOALKYLAMINS AND THEIR APPLICATION AS PHARMACEUTICAL DRUGS 2003
  • Shtrobel' Khartmut
  • Vol'Fart Paulus
  • Belov Peter
RU2337094C2
THIOPHENE DERIVATIVES 2010
  • Chzhan Khehshehn
  • Tszehn Guankhuaj
  • Gao Ifehj
RU2536865C2
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY 2019
  • Ghosh, Shomir
  • Glick, Gary
  • Katz, Jason
  • Roush, William
  • Seidel, Hans, Martin
  • Shen, Dong-Ming
  • Venkatraman, Shankar
RU2795108C2
THIENO[2,3-c]QUINOLIN-4-ONE DERIVATIVES, USEFUL IN TREATMENT OF ERK-DEPENDENT DISEASE 2011
  • Nakamura Jusuke
  • Matsuo E
  • Khisada Sodzi
  • Akhmed Fer'Jan
  • Khantli Rehjmond
  • Sadzhdzhadi-Khashemi Zokhrekh
  • Dzhenkins Dehvid M.
  • Kargbo Robert B.
  • Tsuj Vehneh
  • Gouan Polivina Kholisija F.
  • Uolker Dzhoehl R.
  • Dekorne Ehlen
  • Gurram Makhender
RU2574398C2
DISUBSTITUTED FURANONES, THIAZOLES AND PENTENONES AS INHIBITORS OF CYCLOOXYGENASE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT 1994
  • Iv Djusharm
  • Zhak I.Got'E
  • Petpibun Prehzit
  • Iv Leblan
  • Zhaoin Vang
  • Serzh Lezhe
  • Mishel' Ter'En
RU2131423C1
AZAINDOL DERIVATIVES AS FACTOR Xa INHIBITORS 2004
  • Nazare Mark
  • Vener Fol'Kmar
  • Uill Dehvid Uill'Jam
  • Ritter Kurt
  • Urmann Mattias
  • Matter Khans
RU2330853C2
TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING 1996
  • Allen Jakob Daplehntir
  • Kelvin Kuper
RU2161158C2
CARBOXAMIDE COMPOUNDS AND USE THEREOF AS CALPAIN INHIBITORS 2010
  • Kling Andreas
  • Jantos Katja
  • Mak Khel'Mut
  • Meller Akhim
  • Khornberger Vil'Frid
  • Bakfish Gizela
  • Lao Jan'Bin'
  • Nejsen Mar'Olen
RU2567392C2
ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION 1994
  • Uitajak Dzhon
  • Z'Ju Chu-Bajao
  • Sileki-Dzurdz Tais Motria
  • Olson Richard Ehrik
  • Degrado Uill'Jam Frehnk
  • Kejn Gehri Ehjvonn
  • Vatt Duglas Gaj
  • Pinto Donald
RU2149871C1
PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) 2018
  • Eriksson, Anna
  • Grin, Nil
  • Gustafson, Gari
  • Khan, Binsun
  • Lanchia, Ml. Devid R.
  • Mitchell, Lorna
  • Richard, Devid
  • Shelekhin, Tatyana
  • Smit, Chejz K.
  • Van, Chzhungo
  • Chzhen, Syaochzhan
RU2736217C2

RU 2 338 743 C2

Authors

Shtrobel' Khartmut

Vol'Fart Paulus

Dates

2008-11-20Published

2003-07-24Filed